Septorhinoplasty and Pain Score Course

NCT07015229 | Not Yet Recruiting

• 1 other identifier: haseki pacu cevahir
• Study Type: observational
• Target: 78
• Locations: 0 countries
• Sites: N/A

Brief Summary

To provide scientific contribution to more effective and timely pain management strategies in the postoperative period by evaluating the time-dependent course of pain scores and the effect of analgesic intervention timing on clinical outcomes in patients who underwent septorhinoplasty and who are followed in the postanesthetic care unit.

Conditions

Visual Analogue Scale

Outcome Measures

Primary Outcomes (1)

• visual analogue scale

  0:no pain, 10:worst pain

  60 minutes

Interventions

septorhinoplasty PROCEDURE

To provide scientific contribution to more effective and timely pain management strategies in the postoperative period by evaluating the time-dependent course of pain scores and the effect of analgesic intervention timing on clinical outcomes in patients who underwent septorhinoplasty and who are followed in the postanesthetic care unit.

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients aged 18-65 years with ASA 1-3 who underwent elective septorhinoplasty

You may qualify if:

• Being 18 years of age or older,
• Being in ASA I-III class,
• Having undergone septorhinoplasty surgery under general anesthesia under elective conditions,
• Being monitored for at least 30 minutes in postoperative,
• Being conscious and able to assess pain with VAS.

You may not qualify if:

• Patients who have undergone surgical procedures other than septorhinoplasty (e.g. laparoscopic, gynecological, orthopedic, etc.)
• Inability to assess pain due to impaired consciousness, agitation, or sedation in the postoperative period
• History of opioid derivatives or continuous analgesic use in the preoperative period
• Cognitive impairment, psychiatric disease at a level that prevents communication, severe visual or hearing impairment
• History of neurological or neuromuscular disease
• Having undergone revision septorhinoplasty or other revision surgery
• Patients with VAS≥4 during their follow-up in the postoperative,

Sponsors & Collaborators

• Istinye University: lead

Related Publications (2)

• Alshehri AA. Comparative Evaluation of Postoperative Pain Scores and Opioid Consumption in Septorhinoplasty After Administration of Single-Dose Preemptive Paracetamol and Ibuprofen: A Randomized Controlled Trial. Int Arch Otorhinolaryngol. 2023 Aug 4;27(3):e471-e477. doi: 10.1055/s-0042-1749386. eCollection 2023 Jul.

  PMID: 37564463 RESULT

• Perianez CAH, Castillo-Diaz MA, Barbosa MH, De Mattia AL. Pain Predictors in Patients in the Postanesthesia Care Unit. J Perianesth Nurs. 2024 Aug;39(4):652-658. doi: 10.1016/j.jopan.2023.11.010. Epub 2024 Feb 3.

  PMID: 38310508 RESULT

Central Study Contacts

ilke dolgun

CONTACT

+905555485632; ilkeser2004@gmail.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: assoc. prof.

Study Record Dates

• First Submitted: June 3, 2025
• First Posted: June 11, 2025
• Study Start: June 25, 2025
• Primary Completion: January 4, 2026
• Study Completion: January 20, 2026
• Last Updated: June 27, 2025

Record last verified: 2025-06

Data Sharing

• IPD Sharing: Will not share